Shares of Kanabo Group Plc (LON: KNB) spiked 223% higher after the medical cannabis device maker listed on London’s primary market earlier today at 6.5p making it the second cannabis firm currently listed on the LSE.
The company produces and sells the medical-grade VapePod, which can be used in combination with high-quality cannabis extract formulas by patients with medicinal cannabis prescriptions. It got regulatory approval in Israel.
Kanabo is headquartered in Israel and was founded in 2018 by Avihu Tamir who had prior experience importing and selling flower vaporisers for use by patients in Israel’s medical cannabis programme.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Tamir was part of the programme in 2012 when he spotted the need for vaporisers to help patients with medical cannabis prescriptions use the product without having to ‘roll a joint’ as was the case then.
The company’s VapePod is the only vaporiser that can deliver a measured dose of a cannabis extract product globally and has an addressable market value of up to €500 million over the next four years.
Kanabo listed on the London Stock Exchange (LSE) via a reverse merger with Spinnaker Opportunities PLC a shell company that will now trade under the Kanabo Group Plc name.
The company raised £6 million via today’s IPO. The money will be used to market its wellness product range and launch the first clinical trial on a cannabis vape formulation.
Avihu Tamir, Kanabo’s CEO, said: “We had considered other markets but chose the LSE for its deep access to capital and while it has taken longer than expected, or wished, we were sure we would be approved and that we would see cannabis companies on the LSE,”
Tamir added that he expects at least 50 cannabis companies to list on the LSE in the next few years in an explosion that could make London a major hub for cannabis companies.
Kanabo Group share price.
Kanabo Group shares spiked 223% higher to trade at 21p rising from its IPO price of 6.5p.
